KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 116 filers reported holding KURA ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $522,000 | -27.3% | 52,493 | +0.6% | 0.00% | 0.0% |
| Q4 2019 | $718,000 | -8.8% | 52,195 | +0.6% | 0.00% | 0.0% |
| Q3 2019 | $787,000 | -68.7% | 51,902 | -59.3% | 0.00% | -50.0% |
| Q2 2019 | $2,511,000 | +64.7% | 127,534 | +38.7% | 0.00% | 0.0% |
| Q1 2019 | $1,525,000 | +18.6% | 91,934 | +0.4% | 0.00% | +100.0% |
| Q4 2018 | $1,286,000 | -22.6% | 91,573 | -3.5% | 0.00% | -50.0% |
| Q3 2018 | $1,661,000 | – | 94,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |